Search

Search Results
Results 1 - 10 of 351 for Vaccines
  • Supplier Profile
    Vaxxas is focussed on enhancing the performance of existing and next generation vaccines through the development and commercialization of the company's novel vaccine delivery technology - the...
  • Supplier Profile
    Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). TCI taps into the unique...
  • Supplier Profile
    Australian company Prima BioMed Ltd develops and commercialises technology arising from immunology and cancer immunotherapy. The company holds commercial rights to technologies developed at the...
  • Supplier Profile
    BIONOSTRA is a biotechnology company performing breakthrough technology for the development of biologic vaccines and gene therapy. The Company uses the many advances made in the fields of...
  • Supplier Profile
    BioSante is developing a pipeline of hormone therapy products to treat both men and women. BioSante's hormone therapy products are gel formulations for transdermal administration that deliver...
  • Supplier Profile
    Monogram is a leader in developing and commercializing innovative products to help guide and improve the treatment of infectious diseases, cancer and other serious diseases. Our molecular...
  • Supplier Profile
    Novavax, Inc. is a specialty biopharmaceutical company engaged in the research, development and commercialization of proprietary products focused on drug delivery and biological technologies. The...
  • Supplier Profile
    NanoSight delivers the world’s most versatile and proven multi-parameter nanoparticle analysis in a single instrument. NanoSight’s “Nanoparticle Tracking Analysis” (NTA)...
  • Supplier Profile
    NanoBio® is a biopharmaceutical company focused on developing and commercializing topical and mucosal antimicrobial products derived from its patented NanoStat™ technology platform. The...
  • Article - 5 Feb 2004
    BioSante Pharmaceuticals, Inc. today announced an update on recent developments of its calcium phosphate-based nanotechnology (CAP). Posted February 2 2004